Virios Therapeutics, Inc.
VIRI
Revenue
0.00
0.000.00%
-Assets
3.64M
▲411.28k▲12.75%
3 Months ChangeLiabilities
500.08k
▼-70.01k▼-12.28%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-20
Form 8-K
ID: 0001558370-24-009327
2024-06-12
Form 8-K
ID: 0001558370-24-009066
2024-05-20
Form 8-K
ID: 0001558370-24-008450
2024-05-10
Form 10-Q
ID: 0001558370-24-007713
2024-05-09
Form 8-K
ID: 0001558370-24-007474
2024-05-07
Form 8-K
ID: 0001558370-24-007096
2024-03-06
Form 8-K
ID: 0001558370-24-002613
2024-02-29
Form 8-K
ID: 0001558370-24-002113
2024-02-27
Form 8-K
ID: 0001558370-24-001840
2024-01-03
Form 8-K
ID: 0001558370-24-000019